Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques. 1992

S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.

Simian immunodeficiency virus (SIV) was used as a model to study the protective efficacy of an immunization regimen currently being evaluated as candidate vaccines against HIV in human subjects. Four Macaca fascicularis were first immunized with recombinant vaccinia virus expressing the envelope glycoprotein gp160 of SIVmne and then boosted with subunit gp160. Both cell-mediated and humoral immune responses against SIV, including neutralizing antibodies, were elicited. The macaques were shown to be protected from a homologous virus infection as determined by serology, lymphocyte cocultivation, polymerase chain reactions and in vivo transmission analyses. Four unimmunized control animals were readily infected. However, viremia in infected control animals could decrease substantially following the initial phase of infection so that persistent infection might not be readily detectable.

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
August 2009, Journal of virology,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
March 1996, Vaccine,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
April 1999, Journal of virology,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
September 2002, Virology,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
November 1990, AIDS research and human retroviruses,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
May 1995, The Journal of infectious diseases,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
August 2003, Journal of virology,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
June 1996, The Journal of infectious diseases,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
May 2008, Virology,
S L Hu, and K Abrams, and L Misher, and V Stallard, and P Moran, and J M Zarling, and A J Langlois, and L Kuller, and W R Morton, and R E Benveniste
June 2000, AIDS (London, England),
Copied contents to your clipboard!